Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/17150
Title: | Medical nanotechnology: the obstacles hampering a future dominant market | Authors: | BOSETTI, Rita | Issue Date: | 2014 | Publisher: | TEKNOSCIENZE PUBL | Source: | CHIMICA OGGI-CHEMISTRY TODAY, 32 (1), p. 50-53 | Abstract: | Nanomedicine, the application of nanotechnology in the prevention, diagnosis and treatment of diseases, takes advantage of materials on the nanometer scale. Although business experts find it difficult to estimate the volume and growth rate of the nanomedicine market, it is expected to grow significantly in the next decade. Despite nanotherapeutics have promising expectations for the future of healthcare, some impediments blocking their success have to be removed: consumer as well as physician distrust, ineffective regulation of new and generic products, insurance market failure, weak patent protection and a low interest by big pharma due to their high acquisition cost. However, to assess the total cost of nanodrugs, all direct and indirect costs of treatment as well as health effects should be included. | Notes: | Hasselt Univ, Dept Appl Econ, BE-3500 Hasselt, Belgium. | Keywords: | nanotechnology; nanomedicine; cancer; challenges; cost-effectiveness analysis;Nanotechnology; nanomedicine; cancer; challenges; cost-effectiveness analysis | Document URI: | http://hdl.handle.net/1942/17150 | ISSN: | 0392-839X | ISI #: | 000339905200016 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2015 |
Appears in Collections: | Research publications |
Show full item record
WEB OF SCIENCETM
Citations
3
checked on Mar 22, 2024
Page view(s)
30
checked on Aug 25, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.